Real World Evidence on the Use of Medical Cannabis in Pediatrics
Recruiting now
Conditions studied: Cancer, Epilepsy, Neurodevelopmental Disorders
In brief
CAN-RWE is an observational study that is following 500 children who have authorizations for medical cannabis for two years from across Canada.
Key facts
- Study ID
- NCT05863910
- Run by
- University of Manitoba
- People needed
- 500
- Starts
- 2023-11-20
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2023-11-30
Who can join
Age: 3 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 3 to 17 years
- have a medical document provided by a prescribing health care practitioner (i.e. physician, nurse practitioner, etc.) for the use of medical cannabis
- medical cannabis is authorized for pain, sleep, mood, behaviour, seizures, cancer or cancer-treatment related symptom management
- ability to respond to electronic questionnaires in English
You may not qualify if…
- individuals using cannabis for medical purposes without a medical cannabis authorization from a health care provider
- those only using cannabis recreationally
Where it is running
- U Manitoba — Winnipeg, Manitoba, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.